NEW YORK (Reuters Health) - Patients with liver tumors called hepatocellular carcinomas and who have few other treatment options are likely to benefit from proton beam radiation therapy, Japanese researchers report in the journal Cancer.
NEW YORK (Reuters Health) - Patients with liver tumors called hepatocellular carcinomas and who have few other treatment options are likely to benefit from proton beam radiation therapy, Japanese researchers report in the journal Cancer.
